Clinical indication# | Certainty of evidence¶ | Recommendation |
Prevention of hypercapnia in COPD exacerbation | ⊕⊕ | Conditional recommendation against |
Hypercapnia with COPD exacerbation | ⊕⊕⊕⊕ | Strong recommendation for |
Cardiogenic pulmonary oedema | ⊕⊕⊕ | Strong recommendation for |
Acute asthma exacerbation | No recommendation made | |
Immunocompromised | ⊕⊕⊕ | Conditional recommendation for |
De novo respiratory failure | No recommendation made | |
Post-operative patients | ⊕⊕⊕ | Conditional recommendation for |
Palliative care | ⊕⊕⊕ | Conditional recommendation for |
Trauma | ⊕⊕⊕ | Conditional recommendation for |
Pandemic viral illness | No recommendation made | |
Post-extubation in high-risk patients (prophylaxis) | ⊕⊕ | Conditional recommendation for |
Post-extubation respiratory failure | ⊕⊕ | Conditional recommendation against |
Weaning in hypercapnic patients | ⊕⊕⊕ | Conditional recommendation for |
#: all in the setting of acute respiratory failure; ¶: certainty of effect estimates: ⊕⊕⊕⊕, high; ⊕⊕⊕, moderate; ⊕⊕, low; ⊕, very low.